Investigational Drug Information for AVP-786
✉ Email this page to a colleague
What is the development status for investigational drug AVP-786?
AVP-786 is an investigational drug.
There have been 17 clinical trials for AVP-786.
The most recent clinical trial was a Phase 3 trial, which was initiated on December 1st 2015.
The most common disease conditions in clinical trials are Psychomotor Agitation, Dementia, and Alzheimer Disease. The leading clinical trial sponsors are Avanir Pharmaceuticals and [disabled in preview].
There are eighty-one US patents protecting this investigational drug and one hundred and seventy-two international patents.
Summary for AVP-786
| US Patents | 81 |
| International Patents | 172 |
| US Patent Applications | 123 |
| WIPO Patent Applications | 8 |
| Japanese Patent Applications | 3 |
| Clinical Trial Progress | Phase 3 (2015-12-01) |
| Vendors | 13 |
Recent Clinical Trials for AVP-786
| Title | Sponsor | Phase |
|---|---|---|
| Study to Assess the Efficacy, Safety, and Tolerability of AVP-786 for the Treatment of Agitation in Patients With Dementia of the Alzheimer's Type | Avanir Pharmaceuticals | Phase 3 |
| Assessment of the Efficacy, Safety, and Tolerability of AVP-786 for the Treatment of Agitation in Patients With Dementia of the Alzheimer's Type | Avanir Pharmaceuticals | Phase 3 |
| Efficacy, Safety, and Tolerability of AVP-786 for the Treatment of Negative Symptoms of Schizophrenia | Avanir Pharmaceuticals | Phase 2/Phase 3 |
Clinical Trial Summary for AVP-786
Top disease conditions for AVP-786
Top clinical trial sponsors for AVP-786
US Patents for AVP-786
| Drugname | Patent Number | Patent Title | Patent Assignee | Estimated Expiration |
|---|---|---|---|---|
| AVP-786 | ⤷ Sign Up | Bupropion as a modulator of drug activity | ANTECIP BIOVENTURES II LLC (New York, NY) | ⤷ Sign Up |
| AVP-786 | ⤷ Sign Up | Bupropion as a modulator of drug activity | ANTECIP BIOVENTURES II LLC (New York, NY) | ⤷ Sign Up |
| AVP-786 | ⤷ Sign Up | Compositions and methods for increasing the metabolic lifetime of dextromethorphan and related pharmacodynamic effects | ANTECIP BIOVENTURES II LLC (New York, NY) | ⤷ Sign Up |
| AVP-786 | ⤷ Sign Up | Compositions and methods for increasing the metabolic lifetime of dextromethorphan and related pharmacodynamic effects | ANTECIP BIOVENTURES II LLC (New York, NY) | ⤷ Sign Up |
| AVP-786 | ⤷ Sign Up | Compositions and methods comprising bupropion or related compounds for sustained delivery of dextromethorphan | ANTECIP BIOVENTURES II LLC (New York, NY) | ⤷ Sign Up |
| AVP-786 | ⤷ Sign Up | Compositions and methods for increasing the metabolic lifetime of dextromethorphane and related pharmacodynamic effects | ANTECIP BIOVENTURES II LLC (New York, NY) | ⤷ Sign Up |
| >Drugname | >Patent Number | >Patent Title | >Patent Assignee | >Estimated Expiration |
International Patents for AVP-786
| Drugname | Country | Document Number | Estimated Expiration | Related US Patent |
|---|---|---|---|---|
| AVP-786 | Australia | AU2014346807 | 2033-11-05 | ⤷ Sign Up |
| AVP-786 | Australia | AU2015350559 | 2033-11-05 | ⤷ Sign Up |
| AVP-786 | Australia | AU2018203638 | 2033-11-05 | ⤷ Sign Up |
| AVP-786 | Australia | AU2019201548 | 2033-11-05 | ⤷ Sign Up |
| AVP-786 | Australia | AU2019223187 | 2033-11-05 | ⤷ Sign Up |
| AVP-786 | Australia | AU2019236614 | 2033-11-05 | ⤷ Sign Up |
| >Drugname | >Country | >Document Number | >Estimated Expiration | >Related US Patent |
